发明名称 可溶性血管内皮増殖因子受容体1量を指標とする検査方法
摘要 The present invention relates to a test method for predicting a cardiovascular event, and provides a test method for evaluating the risk of the onset of a cardiovascular event specific to a chronic kidney disease (CKD) patient. The risk of the onset of a cardiovascular event can be predicted and a high risk group can be detected in CKD patients by measuring the level of a soluble vascular endothelial proliferation factor receptor 1 (soluble fms-like tyrosine kinase-1: sFlt-1) in blood in each of the CKD patients. Specifically, the prediction and the detection can be achieved through (1) a step of measuring the quantity of sFlt-1 in a sample collected from a chronic kidney disease patient in vitro; and (2) setting any value selected from 90 to 130 pg/mL as a cut-off value and detecting the risk of the onset of the cardiovascular event in the chronic kidney disease patient when a measurement value is equal to or higher than the cut-off value.
申请公布号 JP6083647(B2) 申请公布日期 2017.02.22
申请号 JP20130536114 申请日期 2012.09.04
申请人 公益財団法人ヒューマンサイエンス振興財団 发明人 和田 啓道
分类号 G01N33/53;G01N33/531 主分类号 G01N33/53
代理机构 代理人
主权项
地址